Highlights
NASDAQ: BCLI       Brainstorm Cell
Last Price Today's Change   Day's Range   Trading Volume
10.365   +0.285 (2.83%)  9.93 - 10.55  25,720

Overview

 
Avg Volume (4 weeks):981,135
4 Weeks Range:8.71 - 17.95
4 Weeks Price Volatility (%):
17.91%
52 Weeks Range:3.58 - 17.95
52 Weeks Price Volatility (%):
47.22%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is a developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2753  2980  512  3157 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 OAS 0.155-0.014 
 NIO 29.93+2.42 
 NOK 3.309-0.741 
 PINS 67.391+18.141 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 GE 7.535+0.115 
 F 8.10+0.40 
 XOG 0.271-0.062